The Throat-Clearing Function Test (Qingyan functional evaluation) is a standardized biological assay used to substantiate throat-sooaking and pharyngeal-comfort health claims for functional foods, herbal formulations, and registered health products. Based on recognized pharmacological models such as carrageenan-induced paw edema in rats, xylene-induced ear edema in mice, and controlled human feeding trials, this evaluation supports product registration under China's health food regulatory framework. This article explains the test principles, sample requirements, experimental methods, judgment criteria, and practical applications of throat-clearing function testing performed by accredited third-party laboratories.
Technical Overview
The throat-clearing function test is a functional evaluation designed to determine whether a test substance can relieve pharyngeal discomfort, reduce throat irritation, and support mucosal comfort. In China's health food registration system, the "Qingyan" (throat-clearing) claim is one of the recognized non-nutrient health functions, and products bearing this claim on the "blue hat" label must provide scientific evidence generated through standardized evaluation methods.
The evaluation is scientifically grounded in the inflammatory nature of common throat complaints. Chronic pharyngeal discomfort—dryness, soreness, foreign-body sensation, and irritating cough—is closely associated with local inflammation of the pharyngeal mucosa. Therefore, the classical evaluation combines anti-inflammatory pharmacology models in laboratory animals with symptom-based human clinical assessment.
The primary regulatory and technical references include the Technical Standards for Health Food Testing and Evaluation (2003 Edition), the updated Health Food Function Testing and Evaluation Methods (2023 Edition) issued under the State Administration for Market Regulation (SAMR) framework, and supporting laboratory standards such as GB 14925 (laboratory animal housing), GB 14924 (laboratory animal feeds), and GB/T 35892 (ethical review of laboratory animal welfare). Testing is typically performed in accredited third-party laboratories holding ISO/IEC 17025 accreditation and operating under GLP-aligned quality management systems.
Testing Samples
Health Food Finished Products
Finished dosage forms are the most common test articles, including throat lozenges, herbal candies, pastilles, oral liquids, granules, tablets, capsules, and botanical beverage concentrates. The test article should be the final marketed formulation, or a preparation equivalent to it in composition and processing.
Botanical and Traditional Formulation Ingredients
Raw materials and semi-finished extracts are also evaluated, particularly those derived from traditional throat-soothing botanicals such as licorice root, honeysuckle flower, boat-fruited sterculia seed, platycodon root, menthol-bearing mint, and chrysanthemum. Compound formulations combining multiple botanicals are tested as complete systems to reflect their intended synergistic use.
Sample Submission Requirements
- Sufficient quantity of the test article to cover all dose groups for the full dosing period (typically several kilograms or liters depending on dosage form)
- Certificate of analysis, batch number, production date, and shelf-life documentation
- Recommended human daily dose information, which serves as the basis for animal dose conversion
- Physical and chemical characterization data confirming stability and compositional consistency
Testing Items
The evaluation encompasses both animal-model endpoints and, where applicable, human clinical endpoints:
- Paw swelling degree and swelling inhibition rate in the carrageenan-induced rat paw edema model
- Ear edema degree and edema inhibition rate in the xylene-induced mouse ear edema model
- Body weight, food intake, and general condition monitoring throughout the animal dosing period
- Human symptom scores: throat dryness, soreness, foreign-body sensation, and irritating cough
- Pharyngeal signs assessed by otolaryngological examination: mucosal congestion, lymphoid follicle hyperplasia of the posterior pharyngeal wall, and mucous secretion status
- Safety indicators in the human trial: routine blood and urine tests, liver and kidney function indices, blood pressure, pulse, and electrocardiogram
Testing Methods
Carrageenan-Induced Rat Paw Edema Test
Healthy SD or Wistar rats are randomly assigned to a negative control group and low-, mid-, and high-dose test groups (typically 5-, 10-, and 30-fold the recommended human dose after body-surface conversion). The test article is administered orally by gavage for 30 consecutive days. On the final day, a 1% carrageenan saline suspension is injected into the subplantar tissue of one hind paw. Paw volume is measured with a plethysmometer immediately before injection and at 1, 2, 3, 4, and 6 hours afterward. Swelling degree is calculated as the change in paw volume from baseline, and the swelling inhibition rate is compared between the test and control groups.
Xylene-Induced Mouse Ear Edema Test
Healthy KM or ICR mice receive the test article by oral gavage for 30 days using a similar dose-group design. After the final administration, xylene is applied topically to both surfaces of one ear to induce acute edema. After the prescribed exposure period, circular discs are punched from corresponding sites of both ears and weighed. The difference in disc weight between the treated and untreated ears represents the edema degree, which is statistically compared across groups.
Human Feeding Trial
Where the applicable protocol requires clinical substantiation, a randomized, double-blind, placebo-controlled parallel trial is conducted. Eligible subjects are adults with chronic pharyngeal discomfort symptoms of defined duration, excluding individuals with organic upper-airway disease or relevant contraindications. Subjects consume the test product or placebo daily for approximately 30 to 45 days. Symptom scores and pharyngeal signs are recorded before and after the intervention by qualified physicians, and safety laboratory examinations are performed at baseline and endpoint.
Judgment Criteria and Data Processing
- Animal studies: the test article is considered positive when edema degree is significantly lower than the control group (P < 0.05) at multiple observation time points, with no adverse effect on body weight or general condition
- Human trials: efficacy is supported by significant improvement in total symptom and sign scores and a higher effective rate versus placebo, with all safety indicators remaining within normal ranges
- Statistical analysis: quantitative data are processed using t-tests or ANOVA; enumeration data such as effective rates are analyzed using chi-square tests
- Integrated conclusion: functional claim substantiation requires positive results obtained under the currently applicable evaluation method together with an acceptable safety profile
Applications
- Health food registration dossiers supporting the throat-clearing function claim on product labels
- Research and development support for formulation screening, botanical combination optimization, and dose-response confirmation
- Quality consistency verification demonstrating that functional efficacy is maintained across production batches
- Scientific substantiation for marketing claims and consumer communication materials
- Evidence packages for literature publication and international market submissions, where local regulatory requirements permit
FAQ
Is animal testing or a human trial required for the throat-clearing claim?
The required study design depends on the applicable evaluation method version and the product category. Historically, animal anti-inflammatory models served as the core evidence, while current regulatory trends emphasize well-controlled human feeding trials for sensory-type claims. Sponsors should verify the latest SAMR evaluation requirements before initiating a study program.
How long does the complete evaluation take?
The animal study typically requires six to eight weeks, including acclimation, 30 days of dosing, and the challenge phase. A human trial generally requires three to six months, accounting for ethics approval, subject recruitment, the 30-to-45-day intervention period, and data analysis.
What determines a positive test result?
A positive result requires statistically significant reduction of edema in animal models or significant improvement of pharyngeal symptom and sign scores in human subjects compared with controls, without any treatment-related safety abnormalities.
How are animal doses designed?
Dose levels are derived from the recommended human daily intake using body-surface-area conversion, commonly setting low, mid, and high doses at approximately 5, 10, and 30 times the human equivalent dose to characterize the dose-response relationship.
Can the data be used for markets outside China?
While the study design follows Chinese health food evaluation methods, the generated pharmacological and clinical data are widely accepted as general scientific substantiation. Companies should nevertheless align claim language and study design with the specific requirements of each target market, such as EFSA guidance in the EU or FTC substantiation principles in the United States.
Why Choose ZKGX?
- State-of-the-art analytical equipment
- Highly qualified scientific team
- Fast turnaround time
- Competitive pricing